| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,407 |
12,192 |
$2.01M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,188 |
8,010 |
$1.95M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,715 |
2,679 |
$866K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,749 |
2,674 |
$334K |
| 87631 |
|
2,480 |
2,458 |
$310K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,927 |
2,758 |
$123K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
901 |
896 |
$86K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
434 |
429 |
$74K |
| 80053 |
Comprehensive metabolic panel |
6,950 |
6,650 |
$71K |
| 71045 |
Radiologic examination, chest; single view |
5,236 |
5,140 |
$66K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,403 |
1,358 |
$59K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,830 |
1,814 |
$50K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
102 |
100 |
$49K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,160 |
6,845 |
$48K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
801 |
794 |
$47K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
653 |
646 |
$32K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
437 |
435 |
$25K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
333 |
330 |
$24K |
| 70450 |
Computed tomography, head or brain; without contrast material |
481 |
473 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
3,222 |
3,029 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
997 |
988 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,371 |
2,300 |
$14K |
| 81001 |
|
3,644 |
3,553 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
162 |
158 |
$12K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
91 |
91 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
779 |
772 |
$11K |
| 83690 |
|
1,806 |
1,752 |
$11K |
| 84484 |
|
971 |
828 |
$10K |
| 87070 |
|
1,200 |
1,189 |
$10K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,461 |
1,370 |
$9K |
| 87430 |
|
494 |
491 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
296 |
293 |
$7K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
49 |
49 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
293 |
292 |
$5K |
| 87807 |
|
416 |
413 |
$5K |
| 83605 |
|
442 |
395 |
$4K |
| 80061 |
Lipid panel |
305 |
304 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
45 |
45 |
$3K |
| 84703 |
|
417 |
410 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
41 |
40 |
$2K |
| 87581 |
|
47 |
47 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
47 |
47 |
$1K |
| 87486 |
|
47 |
47 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
376 |
193 |
$914.02 |
| 83880 |
|
26 |
26 |
$873.14 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
43 |
41 |
$546.43 |
| 82150 |
|
73 |
72 |
$391.68 |
| 87077 |
|
39 |
39 |
$387.00 |
| 81025 |
|
24 |
24 |
$176.18 |
| 94761 |
|
978 |
959 |
$130.27 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$60.48 |
| 81002 |
|
12 |
12 |
$27.90 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
29 |
29 |
$10.44 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
13 |
13 |
$0.96 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
49 |
44 |
$0.00 |